QIAGEN N.V.
QGEN
$32.70
-$1.00-2.97%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.83% | 3.69% | 6.12% | 7.49% | 5.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.83% | 3.69% | 6.12% | 7.49% | 5.37% |
| Cost of Revenue | 4.67% | 244.09% | 4.43% | -58.34% | 6.30% |
| Gross Profit | 0.41% | -42.90% | 7.06% | 595.51% | 4.92% |
| SG&A Expenses | 3.22% | 8.58% | 1.74% | 3.80% | -0.54% |
| Depreciation & Amortization | 2.04% | 12.20% | -2.75% | -15.65% | -18.73% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.68% | 361.77% | 3.74% | -39.46% | -0.63% |
| Operating Income | -6.32% | -66.03% | 13.61% | 184.79% | 27.40% |
| Income Before Tax | -28.21% | -13.26% | 15.69% | 156.76% | 16.87% |
| Income Tax Expenses | -38.22% | -96.43% | -74.55% | 176.44% | 33.19% |
| Earnings from Continuing Operations | -25.03% | 22.09% | 32.62% | 152.46% | 12.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.03% | 22.09% | 32.62% | 152.46% | 12.50% |
| EBIT | -6.32% | -66.03% | 13.61% | 184.79% | 27.40% |
| EBITDA | -0.36% | -61.69% | 10.20% | 273.38% | 10.81% |
| EPS Basic | -24.87% | 21.72% | 32.19% | 152.25% | 12.12% |
| Normalized Basic EPS | -9.84% | -64.67% | 13.72% | 190.31% | 24.50% |
| EPS Diluted | -23.84% | 21.94% | 32.49% | 151.54% | 10.75% |
| Normalized Diluted EPS | -9.95% | -64.67% | 13.75% | 189.70% | 24.95% |
| Average Basic Shares Outstanding | -0.22% | 0.31% | 0.34% | 0.41% | 0.35% |
| Average Diluted Shares Outstanding | -0.12% | 0.31% | 0.29% | 1.09% | -0.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |